MRNY — YieldMax MRNA Option Income Strategy ETF

This actively managed exchange-traded fund, known as the YieldMax MRNA Option Income Strategy ETF (MRNY), is engineered to deliver consistent weekly income. It achieves this by strategically issuing call options or initiating call spreads that are tied to shares of MRNA. The fundamental design of this approach is to collect premiums from these options, while also providing investors with a means to participate in any upward movement in MRNA's stock valuation.

Company profile

• Sector: Financial Services
• Industry: Asset Management - Income
• Country: US
• Exchange: AMEX
• Website: https://yieldmaxetfs.com/our-etfs/mrny/

Latest MRNY news

• 2026-10-21 — YieldMax MRNA Option Income Strategy ETF declares $0.8851 dividend (seekingalpha_market)
• 2026-10-14 — YieldMax MRNA Option Income Strategy ETF declares $0.8112 dividend (seekingalpha_market)
• 2026-10-08 — YieldMax MRNA Option Income Strategy ETF announces weekly distribution of $0.7462 (seekingalpha_market)
• 2026-09-30 — YieldMax MRNA Option Income Strategy ETF declares $0.8073 weekly dividend (seekingalpha_market)

Abrir análisis completo

Educational tool only — not investment advice.